Trial Profile
Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-036 [azelastine] in Patients With Seasonal Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jan 2012
Price :
$35
*
At a glance
- Drugs Azelastine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Meda Pharmaceuticals
- 23 Aug 2008 New trial record.